No association between vitamin K intake and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)

被引:0
|
作者
Hoyt, Maggie
Reger, Michael
Zhang, Jianjun
机构
关键词
D O I
10.1158/1538-7445.AM2017-5312
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5312
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Vitamin K intake and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial
    Hoyt, Margaret
    Reger, Michael
    Marley, Andrew
    Fan, Hao
    Liu, Ziyue
    Zhang, Jianjun
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2019, 109 (02): : 392 - 401
  • [2] Association between calcium intake and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    Hoyt, Maggie
    Zhang, Jianjun
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [3] Dietary fat intake and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Arem, Hannah E.
    Mayne, Susan T.
    Sampson, Joshua
    Risch, Harvey
    Stolzenberg-Solomon, Rachael Z.
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [4] Dietary phytoestrogen intake and lung cancer risk: an analysis of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial
    Wang, Qian
    Ru, Meng
    Zhang, Yaning
    Kurbanova, Tamara
    Boffetta, Paolo
    [J]. CARCINOGENESIS, 2021, 42 (10) : 1250 - 1259
  • [5] Serum Vitamin D and Risk of Bladder Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Mondul, Alison M.
    Weinstein, Stephanie J.
    Horst, Ronald L.
    Purdue, Mark
    Albanes, Demetrius
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (07) : 1222 - 1225
  • [6] Serum vitamin D and risk of prostate cancer among black men in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Layne, Tracy M.
    Weinstein, Stephanie
    Ma, Xiaomei
    Graubard, Barry I.
    Mayne, Susan T.
    Albanes, Demetrius
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03)
  • [7] Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Pinsky, Paul F.
    Black, Amanda
    Parnes, Howard L.
    Grubb, Robert
    Crawford, E. David
    Miller, Anthony
    Reding, Douglas
    Andriole, Gerald
    [J]. CANCER EPIDEMIOLOGY, 2012, 36 (06) : E401 - E406
  • [8] Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Hocking, William G.
    Hu, Ping
    Oken, Martin M.
    Winslow, Stephen D.
    Kvale, Paul A.
    Prorok, Philip C.
    Ragard, Lawrence R.
    Commins, John
    Lynch, David A.
    Andriole, Gerald L.
    Buys, Saundra S.
    Fouad, Mona N.
    Fuhrman, Carl R.
    Isaacs, Claudine
    Yokochi, Lance A.
    Riley, Thomas L.
    Pinsky, Paul F.
    Gohagan, John K.
    Berg, Christine D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (10) : 722 - 731
  • [9] The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial - Preface
    Gohagan, JK
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 249S - 250S
  • [10] Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Prorok, PC
    Andriole, GL
    Bresalier, RS
    Buys, SS
    Chia, D
    Crawford, ED
    Fogel, R
    Gelmann, EP
    Gilbert, F
    Hasson, MA
    Hayes, RB
    Johnson, CC
    Mandel, JS
    Oberman, A
    O'Brien, B
    Oken, MM
    Rafla, S
    Reding, D
    Rutt, W
    Weissfeld, JL
    Yokochi, L
    Gohagan, JK
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 273S - 309S